The Role of Ion Channels and Chemokines in Cancer Growth and Metastasis: A Proposed Mode of Action Using Peptides in Cancer Therapy

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Apr 27

PMID 38672613

Authors

Gerald J Mizejewski

Affiliations

Soon will be listed here.

Abstract

Metastasis (Met) largely contributes to the major cause of cancer deaths throughout the world, rather than the growth of the tumor mass itself. The present report brings together several of the pertinent contributors to cancer growth and metastatic processes from an activity standpoint. Such biological activities include the following: (1) cell adherence and detachment; (2) cell-to-cell contact; (3) contact inhibition; (4) the cell interfacing with the extracellular matrix (ECM); (5) tumor cell-to-stroma communication networks; (6) chemotaxis; and (7) cell membrane potential. Moreover, additional biochemical factors that contribute to cancer growth and metastasis have been shown to comprise the following: (a) calcium levels in the extracellular matrix and in intracellular compartments; (b) cation voltage and ATP-regulated potassium channels; (c) selective and non-selective cation channels; and (d) chemokines (cytokines) and their receptors, such as CXCL12 (SDF-1) and its receptor/binding partner, CXCR4. These latter molecular components represent a promising group of an interacting and synchronized set of candidates ideal for peptide therapeutic targeting for cancer growth and metastasis. Such peptides can be obtained from naturally occurring proteins such as alpha-fetoprotein (AFP), an onco-fetal protein and clinical biomarker.

References

Garnuszek P, Wiercioch R, Sztajer H, Karczmarczyk U, Mirowski M . Uptake of radiolabelled modified fragment of human alfa-fetoptrotein by experimental mammary adenocarcinoma: in vitro and in vivo studies. Nucl Med Rev Cent East Eur. 2005; 8(1):6-10. View

Madeja Z, Master A, Michalik M, Sroka J . Contact-mediated acceleration of migration of melanoma B16 cells depends on extracellular calcium ions. Folia Biol (Krakow). 2002; 49(3-4):113-24. View

Butterstein G, Morrison J, Mizejewski G . Effect of alpha-fetoprotein and derived peptides on insulin- and estrogen-induced fetotoxicity. Fetal Diagn Ther. 2003; 18(5):360-9. DOI: 10.1159/000071981. View

Stone M, Hayward J, Huang C, Huma Z, Sanchez J . Mechanisms of Regulation of the Chemokine-Receptor Network. Int J Mol Sci. 2017; 18(2). PMC: 5343877. DOI: 10.3390/ijms18020342. View

Ding Y, Robbins J, Fraser S, Grimes J, Djamgoz M . Comparative studies of intracellular Ca2+ in strongly and weakly metastatic rat prostate cancer cell lines. Int J Biochem Cell Biol. 2005; 38(3):366-75. DOI: 10.1016/j.biocel.2005.07.009. View

Klimatcheva E, Wonderlin W . An ATP-sensitive K(+) current that regulates progression through early G1 phase of the cell cycle in MCF-7 human breast cancer cells. J Membr Biol. 1999; 171(1):35-46. DOI: 10.1007/s002329900556. View

Peinado H, Lavotshkin S, Lyden D . The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol. 2011; 21(2):139-46. DOI: 10.1016/j.semcancer.2011.01.002. View

Mizejewski G . Physiology of alpha-fetoprotein as a biomarker for perinatal distress: relevance to adverse pregnancy outcome. Exp Biol Med (Maywood). 2007; 232(8):993-1004. DOI: 10.3181/0612-MR-291. View

Mizejewski G . Mechanism of Cancer Growth Suppression of Alpha-Fetoprotein Derived Growth Inhibitory Peptides (GIP): Comparison of GIP-34 versus GIP-8 (AFPep). Updates and Prospects. Cancers (Basel). 2013; 3(2):2709-33. PMC: 3757439. DOI: 10.3390/cancers3022709. View

10.

Wonderlin W . Constitutive, translation-independent opening of the protein-conducting channel in the endoplasmic reticulum. Pflugers Arch. 2008; 457(4):917-30. DOI: 10.1007/s00424-008-0545-y. View

11.

Skolnik G, Bagge U, Blomqvist G, Djarv L, Ahlman H . The role of calcium channels and serotonin (5-HT2) receptors for tumour cell lodgement in the liver. Clin Exp Metastasis. 1989; 7(2):169-74. DOI: 10.1007/BF01787021. View

12.

Farber J . The role of calcium ions in toxic cell injury. Environ Health Perspect. 1990; 84:107-11. PMC: 1567653. DOI: 10.1289/ehp.9084107. View

13.

Mizejewski G . Alpha-fetoprotein binding proteins: implications for transmembrane passage and subcellular localization. Life Sci. 1995; 56(1):1-9. DOI: 10.1016/0024-3205(94)00401-d. View

14.

Mizejewski G, Mirowski M, Garnuszek P, Maurin M, Cohen B, Poiesz B . Targeted delivery of anti-cancer growth inhibitory peptides derived from human alpha-fetoprotein: review of an International Multi-Center Collaborative Study. J Drug Target. 2010; 18(8):575-88. DOI: 10.3109/10611861003587243. View

15.

Mizejewski G . The alpha-fetoprotein (AFP) third domain: a search for AFP interaction sites of cell cycle proteins. Tumour Biol. 2016; 37(9):12697-12711. DOI: 10.1007/s13277-016-5131-x. View

16.

Moser B, Wolf M, Walz A, Loetscher P . Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 2004; 25(2):75-84. DOI: 10.1016/j.it.2003.12.005. View

17.

Watanabe H, Vriens J, Janssens A, Wondergem R, Droogmans G, Nilius B . Modulation of TRPV4 gating by intra- and extracellular Ca2+. Cell Calcium. 2003; 33(5-6):489-95. DOI: 10.1016/s0143-4160(03)00064-2. View

18.

Atemezem A, Mbemba E, Marfaing R, Vaysse J, Pontet M, Saffar L . Human alpha-fetoprotein binds to primary macrophages. Biochem Biophys Res Commun. 2002; 296(3):507-14. DOI: 10.1016/s0006-291x(02)00909-9. View

19.

Wonderlin W, Strobl J . Potassium channels, proliferation and G1 progression. J Membr Biol. 1996; 154(2):91-107. DOI: 10.1007/s002329900135. View

20.

Busillo J, Benovic J . Regulation of CXCR4 signaling. Biochim Biophys Acta. 2006; 1768(4):952-63. PMC: 1952230. DOI: 10.1016/j.bbamem.2006.11.002. View